HACKENSACK, N.J.--(BUSINESS WIRE)--ADMA Biologics, Inc. (ADMA), a late-stage biotechnology company focused on the development and commercialization of human plasma and plasma-derived therapeutics, today announced it is scheduled to present at the Rodman & Renshaw Annual Global Investment Conference at 12:05 PM ET on September 11, 2012 at the Waldorf Astoria in New York.
